Clinical trial
Pharmacologic Relapse Prevention for Alcoholic Smokers
NCT00000457 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00000457 |
|---|---|
| Title | Pharmacologic Relapse Prevention for Alcoholic Smokers |
| Official title | Pharmacologic Relapse Prevention for Alcoholic Smokers |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alcoholism, Smoking |
| Intervention type | Drug |
| Interventions | bupropion (Wellbutrin), Placebo |
| Enrollment | 195 |
| Start date | Jun 1, 1998 |
| Primary completion | Apr 1, 2002 |
| Completion | Aug 1, 2007 |
| First posted | Nov 3, 1999 |
| Last update posted | Oct 21, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: